Brief: Gen Ilac Says It Obtains Exclusive Rights For Leqembi With Eisai Europe For Distribution In Turkey
18/12/2025 11:29
Dec 18 (Reuters) - Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret GENIL.IS: GEN ILAC - OBTAINS EXCLUSIVE RIGHTS FOR LEQEMBI WITH EISAI EUROPE FOR DISTRIBUTION IN TURKEY GEN ILAC - LEQEMBI APPROVED IN OVER 40 COUNTRIES FOR ALZHEIMER'S Source text: nIKA9LRJrc Further company coverage: GENIL.IS (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;; +48 58 7696600;))
Recent news on Gen Ilac ve Saglik Urunleri Sanayi Ticaret
See all newsBrief: Gen Ilac Says It Wins Pharmaceutical Tender In Kazakhstan, Expects $1.19 Million Sales Contribution In 2027
Brief: Gen Ilac Says It Participates In Kazakhstan Drug Procurement Tender Via Med Service Plus Authorized By Kazakhstan Representative Office Of Gen Ilac
Brief: Gen Ilac Says It Signs Supply And Distribution Agreement With Incyte On Oct 9
Brief: Gen Ilac Says It Completes Pharmaceutical Manufacturing Plant Investment In Azerbaijan
Brief: Gen Ilac Says It Is To Start Share Buyback Programme For Max 125 Mln Nominal Shares With Allocated Funds Of 1.5 Bln Lira